16.51 USD
↗ 0.22 (1.38%)PRE MARKET (AS OF 04:01 AM EDT)
Eloxx Pharmaceuticals, Inc. Common Stock
ELOXNASDAQ • USD
Market: OPEN
Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is currently trading at $16.51. The technical outlook is "Neutral" and the fundamental picture shows "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (62.7%), a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Sep 10, 2026.
Open?$16.51
High?$16.51
Low?$16.51
Prev. Close?$16.28
Volume?N/A
Avg. Volume?45.7K
Bid / Ask
Bid?$15.64 × 100
Ask?$15.89 × 100
Spread?$0.25
Midpoint?$15.77
Valuation & Ratios
Market Cap?55.9M
Shares Out?4.0M
Float?3.2M
Float %?78.4%
P/E Ratio?N/A
P/B Ratio?-2.48
EPS?-$4.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Employees
7
Market Cap
56.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1998-12-11
Address
P.O. BOX 274
ARLINGTON, MA 02476
Phone: 781-577-5300
ARLINGTON, MA 02476
Phone: 781-577-5300
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?60
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.54Distress
Confidence?44%Low
Short InterestLow
Short % of Float?0.91%Low
Short Interest?28.8K
Days to Cover?1.0
Free Float3.2M
Avg Daily Volume52.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.07Weak
Quick Ratio?0.07Weak
Cash Ratio?0.05Low
Debt/Equity?-0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-2.48CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?62.7%STRONG▾
Peers50
S&P93
ROA?-827.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$58.7M
Fundamentals ratios updated end of day